vs
NorthEast Community Bancorp, Inc.（NECB）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是NorthEast Community Bancorp, Inc.的1.3倍（$35.5M vs $26.4M），NorthEast Community Bancorp, Inc.净利率更高（40.9% vs -304.2%，领先345.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 3.9%），NorthEast Community Bancorp, Inc.自由现金流更多（$50.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 1.8%）
东北社区银行（马里兰州）是一家美国银行控股公司，主要在大西洋中部地区运营，面向个人用户和本地企业提供存款业务、抵押贷款、小微企业融资、财富管理等全品类零售及商业金融服务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NECB vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $26.4M | $35.5M |
| 净利润 | $10.8M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 59.0% | -304.8% |
| 净利率 | 40.9% | -304.2% |
| 营收同比 | 3.9% | 681.7% |
| 净利润同比 | 5.8% | 39.6% |
| 每股收益（稀释后） | $0.78 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $26.4M | $35.5M | ||
| Q3 25 | $27.0M | $5.2M | ||
| Q2 25 | $25.9M | $19.2M | ||
| Q1 25 | $25.5M | $14.7M | ||
| Q4 24 | $25.4M | $4.5M | ||
| Q3 24 | $27.6M | $26.1M | ||
| Q2 24 | $27.0M | $14.4M | ||
| Q1 24 | $25.5M | $13.8M |
| Q4 25 | $10.8M | $-108.1M | ||
| Q3 25 | $11.9M | $-162.3M | ||
| Q2 25 | $11.2M | $-171.9M | ||
| Q1 25 | $10.6M | $-202.5M | ||
| Q4 24 | $10.2M | $-178.9M | ||
| Q3 24 | $12.7M | $-95.8M | ||
| Q2 24 | $12.8M | $-97.5M | ||
| Q1 24 | $11.4M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 59.0% | -304.8% | ||
| Q3 25 | 61.6% | -3327.6% | ||
| Q2 25 | 59.5% | -916.8% | ||
| Q1 25 | 57.4% | -1297.9% | ||
| Q4 24 | 57.0% | -4042.4% | ||
| Q3 24 | 63.6% | -377.1% | ||
| Q2 24 | 65.6% | -697.4% | ||
| Q1 24 | 62.7% | -698.4% |
| Q4 25 | 40.9% | -304.2% | ||
| Q3 25 | 44.0% | -3135.3% | ||
| Q2 25 | 43.1% | -894.2% | ||
| Q1 25 | 41.4% | -1373.3% | ||
| Q4 24 | 40.1% | -3935.5% | ||
| Q3 24 | 45.9% | -367.5% | ||
| Q2 24 | 47.5% | -676.6% | ||
| Q1 24 | 44.5% | -662.4% |
| Q4 25 | $0.78 | $-0.17 | ||
| Q3 25 | $0.87 | $-0.36 | ||
| Q2 25 | $0.82 | $-0.41 | ||
| Q1 25 | $0.78 | $-0.50 | ||
| Q4 24 | $0.74 | $-0.56 | ||
| Q3 24 | $0.95 | $-0.34 | ||
| Q2 24 | $0.97 | $-0.40 | ||
| Q1 24 | $0.86 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $81.2M | $743.3M |
| 总债务越低越好 | $70.0M | $9.6M |
| 股东权益账面价值 | $351.7M | $1.1B |
| 总资产 | $2.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.20× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $81.2M | $743.3M | ||
| Q3 25 | $64.3M | $659.8M | ||
| Q2 25 | $59.4M | $525.1M | ||
| Q1 25 | $89.5M | $500.5M | ||
| Q4 24 | $78.3M | $594.4M | ||
| Q3 24 | $97.8M | $427.6M | ||
| Q2 24 | $113.9M | $474.3M | ||
| Q1 24 | $107.4M | $296.3M |
| Q4 25 | $70.0M | $9.6M | ||
| Q3 25 | $170.0M | $11.9M | ||
| Q2 25 | $135.0M | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $7.0M | $20.5M | ||
| Q2 24 | $47.0M | $22.9M | ||
| Q1 24 | $47.0M | — |
| Q4 25 | $351.7M | $1.1B | ||
| Q3 25 | $344.0M | $1.0B | ||
| Q2 25 | $336.7M | $919.1M | ||
| Q1 25 | $327.2M | $933.9M | ||
| Q4 24 | $318.3M | $1.0B | ||
| Q3 24 | $309.6M | $524.6M | ||
| Q2 24 | $300.0M | $584.4M | ||
| Q1 24 | $288.9M | $401.2M |
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $2.0B | $1.4B | ||
| Q3 24 | $2.0B | $726.5M | ||
| Q2 24 | $1.9B | $775.9M | ||
| Q1 24 | $1.9B | $557.8M |
| Q4 25 | 0.20× | 0.01× | ||
| Q3 25 | 0.49× | 0.01× | ||
| Q2 25 | 0.40× | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 0.02× | 0.04× | ||
| Q2 24 | 0.16× | 0.04× | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $52.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $50.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | 192.3% | -133.1% |
| 资本支出强度资本支出/营收 | 6.6% | 3.5% |
| 现金转化率经营现金流/净利润 | 4.86× | — |
| 过去12个月自由现金流最近4个季度 | $89.9M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $52.6M | $-46.1M | ||
| Q3 25 | $14.1M | $-117.4M | ||
| Q2 25 | $15.6M | $-76.4M | ||
| Q1 25 | $10.9M | $-132.0M | ||
| Q4 24 | $48.7M | $-115.4M | ||
| Q3 24 | $14.4M | $-59.2M | ||
| Q2 24 | $11.1M | $-82.2M | ||
| Q1 24 | $12.9M | $-102.3M |
| Q4 25 | $50.8M | $-47.3M | ||
| Q3 25 | $13.6M | $-117.6M | ||
| Q2 25 | $14.9M | $-79.6M | ||
| Q1 25 | $10.6M | $-133.8M | ||
| Q4 24 | $48.2M | $-116.7M | ||
| Q3 24 | $14.2M | $-63.8M | ||
| Q2 24 | $11.0M | $-83.4M | ||
| Q1 24 | $12.8M | $-109.0M |
| Q4 25 | 192.3% | -133.1% | ||
| Q3 25 | 50.5% | -2272.5% | ||
| Q2 25 | 57.3% | -413.9% | ||
| Q1 25 | 41.4% | -907.4% | ||
| Q4 24 | 189.3% | -2567.7% | ||
| Q3 24 | 51.5% | -244.6% | ||
| Q2 24 | 40.8% | -578.5% | ||
| Q1 24 | 50.3% | -789.9% |
| Q4 25 | 6.6% | 3.5% | ||
| Q3 25 | 1.6% | 4.7% | ||
| Q2 25 | 2.9% | 16.4% | ||
| Q1 25 | 1.5% | 12.4% | ||
| Q4 24 | 2.0% | 28.6% | ||
| Q3 24 | 0.6% | 17.5% | ||
| Q2 24 | 0.5% | 8.2% | ||
| Q1 24 | 0.3% | 48.2% |
| Q4 25 | 4.86× | — | ||
| Q3 25 | 1.18× | — | ||
| Q2 25 | 1.40× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | 4.77× | — | ||
| Q3 24 | 1.14× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 1.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
